CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,202,000 | +853.0% | 61,975 | +357.7% | 0.00% | – |
| Q2 2022 | $336,000 | -80.4% | 13,542 | -59.5% | 0.00% | -100.0% |
| Q1 2021 | $1,715,000 | -46.1% | 33,468 | -34.9% | 0.00% | -50.0% |
| Q4 2020 | $3,181,000 | +145.3% | 51,373 | +117.0% | 0.00% | +100.0% |
| Q3 2020 | $1,297,000 | -27.1% | 23,677 | -23.5% | 0.00% | -33.3% |
| Q2 2020 | $1,780,000 | – | 30,933 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,796,516 | $45,142,000 | 7.90% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $5,790,000 | 4.09% |
| Belmont Global Advisors, Inc. | 175,000 | $1,013,000 | 0.82% |
| Broadfin Capital, LLC | 1,033,668 | $5,985,000 | 0.79% |
| WASATCH ADVISORS LP | 2,650,551 | $15,347,000 | 0.15% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,158,613 | $6,708,000 | 0.09% |
| Artal Group S.A. | 275,000 | $1,592,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 41,355 | $239,000 | 0.05% |
| A.R.T. Advisors, LLC | 33,501 | $193,000 | 0.01% |
| BANQUE PICTET & CIE SA | 50,932 | $295,000 | 0.01% |